[Cardiology].
This article reviews: 1) some of the results of drug eluting stents (SYNTAX and FAME); 2) the questionnable benefit of physical training in heart failure patients (HF-ACTION); 3) the benefit on cardiac remodelling of cardiac resynchronisation in heart failure patients (REVERSE study) and 4) the role of rate over rhythm control in patients with atrial fibrillation and heart failure (AF-CHF study); this article also reports the encouraging evolution of new technology allowing percutaneous implantation of stents-valves. Finally, this article address the screening of athletes for cardiac diseases.
Roguelov
Christan
C
Service de cardiologie, CHUV, 1011 Lausanne. Christan.Roguelov@chuv.ch
Vogt
Pierre
P
Yerly
Patrick
P
Pascale
Patrizio
P
Katz
Eugène
E
Aebischer
Nicole
N
D002304:Cardiac Pacing, Artificial; D002318:Cardiovascular Diseases / Q000175:diagnosis* / Q000628:therapy*; D003645:Death, Sudden / Q000517:prevention & control; D054855:Drug-Eluting Stents; D006801:Humans; D010879:Piperazines / Q000627:therapeutic use; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use; D000068799:Prasugrel Hydrochloride; D013177:Sports; D013876:Thiophenes / Q000627:therapeutic use
D010879:Piperazines; D010975:Platelet Aggregation Inhibitors; D013876:Thiophenes; D000068799:Prasugrel Hydrochloride